52 related articles for article (PubMed ID: 17873613)
21. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
[TBL] [Abstract][Full Text] [Related]
22. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
23. Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas.
Mitomi H; Mori A; Kanazawa H; Nishiyama Y; Ihara A; Otani Y; Sada M; Kobayashi K; Igarashi M
Hepatogastroenterology; 2005; 52(65):1421-6. PubMed ID: 16201087
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
[TBL] [Abstract][Full Text] [Related]
25. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
26. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
[TBL] [Abstract][Full Text] [Related]
27. [Messenger RNA expression of p21WAF1/CIP1 in colorectal carcinoma tissues].
Kobayashi S; Matsushita K; Isono K
Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):457-62. PubMed ID: 9742528
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.
Manne U; Myers RB; Moron C; Poczatek RB; Dillard S; Weiss H; Brown D; Srivastava S; Grizzle WE
Int J Cancer; 1997 Jun; 74(3):346-58. PubMed ID: 9221816
[TBL] [Abstract][Full Text] [Related]
29. Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review.
Han CB; Li F; Ma JT; Zou HW
Cancer Invest; 2012 Dec; 30(10):741-7. PubMed ID: 23075074
[TBL] [Abstract][Full Text] [Related]
30. Meeting the biologic challenge of colorectal metastases.
Wanebo HJ; LeGolvan M; Paty PB; Saha S; Zuber M; D'Angelica MI; Kemeny NE
Clin Exp Metastasis; 2012 Oct; 29(7):821-39. PubMed ID: 23053740
[TBL] [Abstract][Full Text] [Related]
31. Molecular differences in the KRAS gene mutation between a primary tumor and related metastatic sites - case report and a literature review.
Kosakowska EA; Stec R; Charkiewicz R; Skoczek M; Chyczewski L
Folia Histochem Cytobiol; 2010 Dec; 48(4):597-602. PubMed ID: 21478103
[TBL] [Abstract][Full Text] [Related]
32. p21WAF1 mutations and human malignancies.
Shiohara M; Koike K; Komiyama A; Koeffler HP
Leuk Lymphoma; 1997 Jun; 26(1-2):35-41. PubMed ID: 9250785
[TBL] [Abstract][Full Text] [Related]
33. Study of apoptosis-related interactions in colorectal cancer.
Arora H; Qureshi R; Rizvi MA; Shrivastava S; Parihar MS
Tumour Biol; 2016 Nov; 37(11):14415-14425. PubMed ID: 27629291
[TBL] [Abstract][Full Text] [Related]
34. The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review).
Pérez-Sayáns M; Suárez-Peñaranda JM; Gayoso-Diz P; Barros-Angueira F; Gándara-Rey JM; García-García A
Med Oral Patol Oral Cir Bucal; 2013 Mar; 18(2):e219-25. PubMed ID: 23385498
[TBL] [Abstract][Full Text] [Related]
35. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
[TBL] [Abstract][Full Text] [Related]
36. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
Mulder JW; Wielenga VJ; Pals ST; Offerhaus GJ
Histochem J; 1997 Jun; 29(6):439-52. PubMed ID: 9248852
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium.
Burton JL; Wells M
Histopathology; 1998 Oct; 33(4):297-303. PubMed ID: 9822917
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]